CD73 Promotes Tumor Progression in Patients with Esophageal Squamous Cell Carcinoma
Cluster of differentiation (CD)-73 plays pivotal roles in the regulation of immune reactions via the production of extracellular adenosine, and the overexpression of CD73 is associated with worse outcomes in several types of cancers. Here, we identified 167 esophageal squamous cell carcinoma (ESCC)...
Main Authors: | Yen-Hao Chen, Hung-I Lu, Chien-Ming Lo, Shau-Hsuan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/16/3982 |
Similar Items
-
Prognostic Value of SDF-1α Expression in Patients with Esophageal Squamous Cell Carcinoma Receiving Esophagectomy
by: Yen-Hao Chen, et al.
Published: (2020-04-01) -
CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
by: Young Mun Jeong, et al.
Published: (2020-10-01) -
The Impact of Radiotherapy Dose in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
by: Chien-Ming Lo, et al.
Published: (2021-03-01) -
CD73 Severed as a Potential Prognostic Marker and Promote Lung Cancer Cells Migration via Enhancing EMT Progression
by: Zhao-wei Gao, et al.
Published: (2021-11-01) -
Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma
by: Bao-Ye Sun, et al.
Published: (2023-03-01)